Letrozole (Le), a third-generation aromatase inhibitor, is widely used for ovulation induction, particularly in patients with polycystic ovary syndrome (PCOS) (Bhatnagar, 2007; Castillo and Kol, 2024). This evidence concerns the gene CYP19A1 and polycystic ovary syndrome.